Diagnosis and surveillance of late-onset fetal growth restriction
- PMID: 29422212
- DOI: 10.1016/j.ajog.2017.12.003
Diagnosis and surveillance of late-onset fetal growth restriction
Abstract
By consensus, late fetal growth restriction is that diagnosed >32 weeks. This condition is mildly associated with a higher risk of perinatal hypoxic events and suboptimal neurodevelopment. Histologically, it is characterized by the presence of uteroplacental vascular lesions (especially infarcts), although the incidence of such lesions is lower than in preterm fetal growth restriction. Screening procedures for fetal growth restriction need to identify small babies and then differentiate between those who are healthy and those who are pathologically small. First- or second-trimester screening strategies provide detection rates for late smallness for gestational age <50% for 10% of false positives. Compared to clinically indicated ultrasonography in the third trimester, universal screening triples the detection rate of late smallness for gestational age. As opposed to early third-trimester ultrasound, scanning late in pregnancy (around 37 weeks) increases the detection rate for birthweight <3rd centile. Contrary to early fetal growth restriction, umbilical artery Doppler velocimetry alone does not provide good differentiation between late smallness for gestational age and fetal growth restriction. A combination of biometric parameters (with severe smallness usually defined as estimated fetal weight or abdominal circumference <3rd centile) with Doppler criteria of placental insufficiency (either in the maternal [uterine Doppler] or fetal [cerebroplacental ratio] compartments) offers a classification tool that correlates with the risk for adverse perinatal outcome. There is no evidence that induction of late fetal growth restriction at term improves perinatal outcomes nor is it a cost-effective strategy, and it may increase neonatal admission when performed <38 weeks.
Keywords: fetal growth restriction; infant; late-onset disorders; newborn; small-for-gestational age; term birth.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Added value of cerebro-placental ratio and uterine artery Doppler at routine third trimester screening as a predictor of SGA and FGR in non-selected pregnancies.J Matern Fetal Neonatal Med. 2019 Aug;32(15):2554-2560. doi: 10.1080/14767058.2018.1441281. Epub 2018 Mar 4. J Matern Fetal Neonatal Med. 2019. PMID: 29447050 Clinical Trial.
-
Cerebral-placental-uterine ratio as novel predictor of late fetal growth restriction: prospective cohort study.Ultrasound Obstet Gynecol. 2019 Sep;54(3):367-375. doi: 10.1002/uog.20150. Ultrasound Obstet Gynecol. 2019. PMID: 30338593
-
Diagnostic performance of third-trimester ultrasound for the prediction of late-onset fetal growth restriction: a systematic review and meta-analysis.Am J Obstet Gynecol. 2019 May;220(5):449-459.e19. doi: 10.1016/j.ajog.2018.09.043. Epub 2019 Jan 8. Am J Obstet Gynecol. 2019. PMID: 30633918
-
Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy.Am J Obstet Gynecol. 2018 Feb;218(2S):S855-S868. doi: 10.1016/j.ajog.2017.12.004. Am J Obstet Gynecol. 2018. PMID: 29422214 Review.
-
Role of uteroplacental and fetal Doppler in identifying fetal growth restriction at term.Best Pract Res Clin Obstet Gynaecol. 2017 Jan;38:38-47. doi: 10.1016/j.bpobgyn.2016.09.003. Epub 2016 Sep 23. Best Pract Res Clin Obstet Gynaecol. 2017. PMID: 27720309 Review.
Cited by
-
Maternal plasma syndecan-1: a biomarker for fetal growth restriction.J Matern Fetal Neonatal Med. 2023 Dec;36(1):2150074. doi: 10.1080/14767058.2022.2150074. J Matern Fetal Neonatal Med. 2023. PMID: 36597808 Free PMC article.
-
Cerebroplacental ratio as predictor of adverse perinatal outcome in the third trimester.Acta Obstet Gynecol Scand. 2021 Mar;100(3):497-503. doi: 10.1111/aogs.14031. Epub 2020 Nov 4. Acta Obstet Gynecol Scand. 2021. PMID: 33078387 Free PMC article.
-
Uteroplacental-Cerebral Ratio: A Doppler Parameter for Prognostic Prediction of Late-Onset Fetal Growth Restriction: Single Center Prospective Cohort Study.J Clin Med. 2022 Dec 29;12(1):275. doi: 10.3390/jcm12010275. J Clin Med. 2022. PMID: 36615075 Free PMC article.
-
Metabolic profiling and targeted lipidomics reveals a disturbed lipid profile in mothers and fetuses with intrauterine growth restriction.Sci Rep. 2018 Sep 11;8(1):13614. doi: 10.1038/s41598-018-31832-5. Sci Rep. 2018. PMID: 30206284 Free PMC article.
-
Marijuana use, fetal growth, and uterine artery Dopplers.J Matern Fetal Neonatal Med. 2022 Dec;35(25):7717-7724. doi: 10.1080/14767058.2021.1960973. Epub 2021 Sep 1. J Matern Fetal Neonatal Med. 2022. PMID: 34470115 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials